Skip to main content
Fig. 5 | BMC Infectious Diseases

Fig. 5

From: Testing the regulatory framework in South Africa – a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis

Fig. 5

Levels of the inflammatory marker IL-1⍺ in the FGT of participants in the SOC and intervention arm. IL-1⍺ was measured by ELISA in FGT secretions of SOC and intervention group participants pre-treatment and 1, 3 and 5 months post-treatment. Each participant is represented by a symbol-coded dot. The percentages compared to the IL-1⍺ level measured pre-treatment (month 0) are displayed. The shaded area indicates a decrease in IL-1⍺ post-treatment. The summary shows the median and interquartile range

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us